₹15.78
▲ +0.15 +0.96%
As of 27 Jul 2026 · delayed
NSE Listed
Anlon Healthcare Limited (AHCL)
Volume: 55,52,624Avg Vol 1W: 36,16,999.8Avg Vol 1M: 46,83,802.852W Range:₹9.08₹17.28
Key Ratios
Checked 1d agoMarket Cap₹840 Cr
Current Price₹15.78
Previous Close₹15.63
High / Low (52w)₹17.28 / ₹9.08
Volume55,52,624
Avg Vol (1W)36,16,999.8
Avg Vol (1M)46,83,802.8
Stock P/E6.78
Book Value₹43.32
Dividend Yield0%
ROE12.4%
ROA8.8%
Revenue (TTM)₹120 Cr
Revenue Growth—
Profit Margin23.9%
Total Debt₹44 Cr
Shares Outstanding53 Cr
Face Value₹10
EPS (TTM)₹2.33
P/B0.36
Debt / Equity0.19
50 DMA₹15.25
200 DMA₹13.8
Day change+0.96%
Price Chart
₹15.78▲ 72.08% · 1Y
2025-09-032026-07-27
20-day avg volume: 46.8L shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 72% YoY.
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | ₹38 Cr | ₹24 Cr | ₹9 Cr | ₹49 Cr | ₹36 Cr | ₹51 Cr |
| EBITDA | ₹6 Cr | ₹7 Cr | ₹1 Cr | ₹16 Cr | ₹12 Cr | ₹15 Cr |
| Net Profit | ₹5 Cr | ₹3 Cr | ₹-2 Cr | ₹17 Cr | ₹5 Cr | ₹11 Cr |
| EPS | 2.83 | 0.41 | -0.83 | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹24 Cr | ₹9 Cr | ₹49 Cr | ₹120 Cr | ₹33 Cr | ₹52 Cr | ₹36 Cr | ₹55 Cr |
| EBITDA | ₹7 Cr | ₹1 Cr | ₹16 Cr | ₹31 Cr | ₹6 Cr | ₹13 Cr | ₹12 Cr | ₹14 Cr |
| Net Profit | ₹3 Cr | ₹-2 Cr | ₹17 Cr | ₹21 Cr | ₹4 Cr | ₹9 Cr | ₹5 Cr | ₹10 Cr |
| EPS | — | — | — | 6.37 | — | — | — | — |
Balance Sheet
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Total Assets | ₹71 Cr | ₹85 Cr | ₹112 Cr | ₹128 Cr | ₹181 Cr |
| Total Liabilities | ₹69 Cr | ₹83 Cr | ₹104 Cr | ₹107 Cr | ₹101 Cr |
| Equity | ₹2 Cr | ₹2 Cr | ₹7 Cr | ₹21 Cr | ₹80 Cr |
| Total Debt | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹-15 Cr | ₹-2 Cr | ₹-3 Cr | ₹-3 Cr | ₹-22 Cr |
| Investing | ₹-2 Cr | ₹0 Cr | ₹0 Cr | ₹-3 Cr | ₹3 Cr |
| Financing | ₹16 Cr | ₹3 Cr | ₹2 Cr | ₹8 Cr | ₹19 Cr |
| Free Cash Flow | ₹-15 Cr | ₹-2 Cr | ₹-3 Cr | ₹-3 Cr | ₹-22 Cr |
Shareholding
Promoter 52.68% Institutions 2.89% Public 44.43%
Efficiency & Working Capital
ROCE24.8%
Interest Coverage7.6
Dividend Payout—
Debtor Days228 d
Inventory Days153 d
Payable Days60 d
Cash Conversion Cycle320 d
Working Capital Days380 d
Shareholding Details
As of 2026-06-30
Promoter52.7%
FII1.7%
DII1.2%
Institutions2.9%
Public44.4%
Promoter Pledge0%
No. of Shareholders34,671
Shareholding Pattern
Quarterly — figures in %. Latest 11 quarters.
| Period | Oct 2024 | Oct 2024 | Apr 2025 | Apr 2025 | Jun 2025 | Aug 2025 | Aug 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.3% | 70.3% | 70.3% | 70.3% | 52.7% | 70.3% | 70.3% | 52.7% | 52.7% | 52.7% | 52.7% |
| FIIs | 0% | 0% | 0% | 0% | 14.4% | 0% | 0% | 0% | 0.2% | 0.3% | 1.7% |
| DIIs | 29.7% | 0% | 29.7% | 0% | 4.3% | 29.7% | 0% | 2.8% | 4.5% | 4.6% | 1.2% |
| Public | 0% | 29.7% | 0% | 29.7% | 28.6% | 0% | 29.7% | 44.5% | 42.6% | 42.4% | 44.4% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 109 | 109 | 131 | 131 | 9,125 | 135 | 135 | 12,464 | 11,412 | 12,484 | 34,671 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Punitkumar R Rasadia | Shareholding of Promoter and Promoter Group | 35% | 18.59 Cr |
| Meet Atulkumar Vachhani | Shareholding of Promoter and Promoter Group | 17.7% | 9.41 Cr |
| Shree Dwarikadhish Ventures Llp | Public Shareholding | 7.5% | 4.00 Cr |
| Ban Labs Private Limited | Public Shareholding | 5.3% | 2.80 Cr |
| Luv Natwarlal Ukani | Public Shareholding | 1.1% | 60,00,000 |
| Harshad Rasiklal Sheth | Public Shareholding | 1.1% | 60,00,000 |
| Jay Mauleshkumar Ukani | Public Shareholding | 1.1% | 60,00,000 |
| Mamata Punitkumar Rasadia | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rasadia Bhanumati Rameshbhai | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shilpaben Meetbhai Vachhani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rasadia Khush Punitkumar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rameshbhai Maganbhai Ramotiya | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ramotiya Ramaben | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Jayesh Rameshbhai Ramotiya | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sanjay Ramotiya R | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Atulbhai Shyamlal Vachhani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vachhani Bhartiben Atulbhai | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Neha Nirmal Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Gyana Meetbhai Vachhani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vari Meetbhai Vachhani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Anlon Chemical Research Organization | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Anlon Lifescience Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Advintel Medicare Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ramotiya Maganbhai Rameshbhai Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Punitkumar R Rasadia | Chairman / Executive Director / M D / Promoter | 2025 |
| Meet Atulkumar Vachhani | WTD & Executive Director | 2025 |
| Mamata Punitkumar Rasadia | Non-Exec & Non-Independent Dir | 2025 |
| Kannepalli Krishna Murty | Independent Non Exe. Director | 2025 |
| Anandbhai Natwerlal Katkoria | Independent Non Exe. Director | 2025 |
| Pragada Amitabhen Chhaganbha | Company Sec. & Compli. Officer | 2025 |
| Kishan Vinodkumar Raja | Independent Director | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Domestic Sales | ₹116 Cr | 96.8% |
| Export Sales | ₹4 Cr | 3.2% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 55 | 40 | 40 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-30 | Board Meetings | — |
| bonus | 2026-04-24 | Bonus issue 1:1 | — |
| split | 2026-04-24 | Stock Split From Rs.10/- to Rs.2/- | — |
| split | 2026-04-24 | 1:5 | face value change from 10 to 2 |
| bonus | 2026-04-24 | 1:1 | 1:1 Bonus issue of Equity Shares |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 46 | 7 | — |
| 2025 | 0 | 0 | 0 | 46 | 0 | 46 |
| 2025 | 0 | 0 | 0 | 0 | 2 | 2 |
Substantial Acquisitions (SAST)
3 disclosure(s)
Market03/11/2025 - 04/11/2025 · 14,75,992
Market03/11/2025 - 04/11/2025 · 14,75,992
Market09/09/2025 - 11/09/2025 · 22,54,422
Company Information
Incorporated2013
ChairmanPunitkumar R Rasadia
AuditorKaushal Dave & Associates
Investor Email[email protected]
📍 101/102 Silvercoin Complex Opp, Crystal Mall Kalawad Road, Rajkot, Gujarat, 360005
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search